16:11 EDT Tenaya Therapeutics (TNYA) files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNYA:
- Tenaya Therapeutics: Strong Financial Position and Promising Clinical Trial Results Justify Buy Rating
- Biotech Alert: Searches spiking for these stocks today
- Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
- Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
- Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability